Bill Text: IL SB0317 | 2017-2018 | 100th General Assembly | Engrossed


Bill Title: Amends the Authorized Electronic Monitoring in Long-Term Care Facilities Act. Makes a technical change in a Section concerning the short title.

Spectrum: Slight Partisan Bill (Democrat 2-1)

Status: (Engrossed) 2017-05-19 - Committee Deadline Extended-Rule 9(b) May 26, 2017 [SB0317 Detail]

Download: Illinois-2017-SB0317-Engrossed.html



SB0317 EngrossedLRB100 05102 MJP 15112 b
1 AN ACT concerning regulation.
2 Be it enacted by the People of the State of Illinois,
3represented in the General Assembly:
4 Section 5. The Pharmacy Practice Act is amended by changing
5Section 3 as follows:
6 (225 ILCS 85/3)
7 (Section scheduled to be repealed on January 1, 2018)
8 Sec. 3. Definitions. For the purpose of this Act, except
9where otherwise limited therein:
10 (a) "Pharmacy" or "drugstore" means and includes every
11store, shop, pharmacy department, or other place where
12pharmacist care is provided by a pharmacist (1) where drugs,
13medicines, or poisons are dispensed, sold or offered for sale
14at retail, or displayed for sale at retail; or (2) where
15prescriptions of physicians, dentists, advanced practice
16nurses, physician assistants, veterinarians, podiatric
17physicians, or optometrists, within the limits of their
18licenses, are compounded, filled, or dispensed; or (3) which
19has upon it or displayed within it, or affixed to or used in
20connection with it, a sign bearing the word or words
21"Pharmacist", "Druggist", "Pharmacy", "Pharmaceutical Care",
22"Apothecary", "Drugstore", "Medicine Store", "Prescriptions",
23"Drugs", "Dispensary", "Medicines", or any word or words of

SB0317 Engrossed- 2 -LRB100 05102 MJP 15112 b
1similar or like import, either in the English language or any
2other language; or (4) where the characteristic prescription
3sign (Rx) or similar design is exhibited; or (5) any store, or
4shop, or other place with respect to which any of the above
5words, objects, signs or designs are used in any advertisement.
6 (b) "Drugs" means and includes (1) articles recognized in
7the official United States Pharmacopoeia/National Formulary
8(USP/NF), or any supplement thereto and being intended for and
9having for their main use the diagnosis, cure, mitigation,
10treatment or prevention of disease in man or other animals, as
11approved by the United States Food and Drug Administration, but
12does not include devices or their components, parts, or
13accessories; and (2) all other articles intended for and having
14for their main use the diagnosis, cure, mitigation, treatment
15or prevention of disease in man or other animals, as approved
16by the United States Food and Drug Administration, but does not
17include devices or their components, parts, or accessories; and
18(3) articles (other than food) having for their main use and
19intended to affect the structure or any function of the body of
20man or other animals; and (4) articles having for their main
21use and intended for use as a component or any articles
22specified in clause (1), (2) or (3); but does not include
23devices or their components, parts or accessories.
24 (c) "Medicines" means and includes all drugs intended for
25human or veterinary use approved by the United States Food and
26Drug Administration.

SB0317 Engrossed- 3 -LRB100 05102 MJP 15112 b
1 (d) "Practice of pharmacy" means:
2 (1) the interpretation and the provision of assistance
3 in the monitoring, evaluation, and implementation of
4 prescription drug orders;
5 (2) the dispensing of prescription drug orders;
6 (3) participation in drug and device selection;
7 (4) drug administration limited to the administration
8 of oral, topical, injectable, and inhalation as follows:
9 (A) in the context of patient education on the
10 proper use or delivery of medications;
11 (B) vaccination of patients 14 years of age and
12 older pursuant to a valid prescription or standing
13 order, by a physician licensed to practice medicine in
14 all its branches, upon completion of appropriate
15 training, including how to address contraindications
16 and adverse reactions set forth by rule, with
17 notification to the patient's physician and
18 appropriate record retention, or pursuant to hospital
19 pharmacy and therapeutics committee policies and
20 procedures; and
21 (C) administration of injections of
22 alpha-hydroxyprogesterone caproate, pursuant to a
23 valid prescription, by a physician licensed to
24 practice medicine in all its branches, upon completion
25 of appropriate training, including how to address
26 contraindications and adverse reactions set forth by

SB0317 Engrossed- 4 -LRB100 05102 MJP 15112 b
1 rule, with notification to the patient's physician and
2 appropriate record retention, or pursuant to hospital
3 pharmacy and therapeutics committee policies and
4 procedures;
5 (5) vaccination of patients ages 10 through 13 limited
6 to the Influenza (inactivated influenza vaccine and live
7 attenuated influenza intranasal vaccine) and Tdap (defined
8 as tetanus, diphtheria, acellular pertussis) vaccines,
9 pursuant to a valid prescription or standing order, by a
10 physician licensed to practice medicine in all its
11 branches, upon completion of appropriate training,
12 including how to address contraindications and adverse
13 reactions set forth by rule, with notification to the
14 patient's physician and appropriate record retention, or
15 pursuant to hospital pharmacy and therapeutics committee
16 policies and procedures;
17 (6) drug regimen review;
18 (7) drug or drug-related research;
19 (8) the provision of patient counseling;
20 (9) the practice of telepharmacy;
21 (10) the provision of those acts or services necessary
22 to provide pharmacist care;
23 (11) medication therapy management; and
24 (12) the responsibility for compounding and labeling
25 of drugs and devices (except labeling by a manufacturer,
26 repackager, or distributor of non-prescription drugs and

SB0317 Engrossed- 5 -LRB100 05102 MJP 15112 b
1 commercially packaged legend drugs and devices), proper
2 and safe storage of drugs and devices, and maintenance of
3 required records.
4 A pharmacist who performs any of the acts defined as the
5practice of pharmacy in this State must be actively licensed as
6a pharmacist under this Act.
7 (e) "Prescription" means and includes any written, oral,
8facsimile, or electronically transmitted order for drugs or
9medical devices, issued by a physician licensed to practice
10medicine in all its branches, dentist, veterinarian, podiatric
11physician, or optometrist, within the limits of their licenses,
12by a physician assistant in accordance with subsection (f) of
13Section 4, or by an advanced practice nurse in accordance with
14subsection (g) of Section 4, containing the following: (1) name
15of the patient; (2) date when prescription was issued; (3) name
16and strength of drug or description of the medical device
17prescribed; and (4) quantity; (5) directions for use; (6)
18prescriber's name, address, and signature; and (7) DEA number
19where required, for controlled substances. The prescription
20may, but is not required to, list the illness, disease, or
21condition for which the drug or device is being prescribed. DEA
22numbers shall not be required on inpatient drug orders.
23 (f) "Person" means and includes a natural person,
24copartnership, association, corporation, government entity, or
25any other legal entity.
26 (g) "Department" means the Department of Financial and

SB0317 Engrossed- 6 -LRB100 05102 MJP 15112 b
1Professional Regulation.
2 (h) "Board of Pharmacy" or "Board" means the State Board of
3Pharmacy of the Department of Financial and Professional
4Regulation.
5 (i) "Secretary" means the Secretary of Financial and
6Professional Regulation.
7 (j) "Drug product selection" means the interchange for a
8prescribed pharmaceutical product in accordance with Section
925 of this Act and Section 3.14 of the Illinois Food, Drug and
10Cosmetic Act.
11 (k) "Inpatient drug order" means an order issued by an
12authorized prescriber for a resident or patient of a facility
13licensed under the Nursing Home Care Act, the ID/DD Community
14Care Act, the MC/DD Act, the Specialized Mental Health
15Rehabilitation Act of 2013, or the Hospital Licensing Act, or
16"An Act in relation to the founding and operation of the
17University of Illinois Hospital and the conduct of University
18of Illinois health care programs", approved July 3, 1931, as
19amended, or a facility which is operated by the Department of
20Human Services (as successor to the Department of Mental Health
21and Developmental Disabilities) or the Department of
22Corrections.
23 (k-5) "Pharmacist" means an individual health care
24professional and provider currently licensed by this State to
25engage in the practice of pharmacy.
26 (l) "Pharmacist in charge" means the licensed pharmacist

SB0317 Engrossed- 7 -LRB100 05102 MJP 15112 b
1whose name appears on a pharmacy license and who is responsible
2for all aspects of the operation related to the practice of
3pharmacy.
4 (m) "Dispense" or "dispensing" means the interpretation,
5evaluation, and implementation of a prescription drug order,
6including the preparation and delivery of a drug or device to a
7patient or patient's agent in a suitable container
8appropriately labeled for subsequent administration to or use
9by a patient in accordance with applicable State and federal
10laws and regulations. "Dispense" or "dispensing" does not mean
11the physical delivery to a patient or a patient's
12representative in a home or institution by a designee of a
13pharmacist or by common carrier. "Dispense" or "dispensing"
14also does not mean the physical delivery of a drug or medical
15device to a patient or patient's representative by a
16pharmacist's designee within a pharmacy or drugstore while the
17pharmacist is on duty and the pharmacy is open.
18 (n) "Nonresident pharmacy" means a pharmacy that is located
19in a state, commonwealth, or territory of the United States,
20other than Illinois, that delivers, dispenses, or distributes,
21through the United States Postal Service, commercially
22acceptable parcel delivery service, or other common carrier, to
23Illinois residents, any substance which requires a
24prescription.
25 (o) "Compounding" means the preparation and mixing of
26components, excluding flavorings, (1) as the result of a

SB0317 Engrossed- 8 -LRB100 05102 MJP 15112 b
1prescriber's prescription drug order or initiative based on the
2prescriber-patient-pharmacist relationship in the course of
3professional practice or (2) for the purpose of, or incident
4to, research, teaching, or chemical analysis and not for sale
5or dispensing. "Compounding" includes the preparation of drugs
6or devices in anticipation of receiving prescription drug
7orders based on routine, regularly observed dispensing
8patterns. Commercially available products may be compounded
9for dispensing to individual patients only if all of the
10following conditions are met: (i) the commercial product is not
11reasonably available from normal distribution channels in a
12timely manner to meet the patient's needs and (ii) the
13prescribing practitioner has requested that the drug be
14compounded.
15 (p) (Blank).
16 (q) (Blank).
17 (r) "Patient counseling" means the communication between a
18pharmacist or a student pharmacist under the supervision of a
19pharmacist and a patient or the patient's representative about
20the patient's medication or device for the purpose of
21optimizing proper use of prescription medications or devices.
22"Patient counseling" may include without limitation (1)
23obtaining a medication history; (2) acquiring a patient's
24allergies and health conditions; (3) facilitation of the
25patient's understanding of the intended use of the medication;
26(4) proper directions for use; (5) significant potential

SB0317 Engrossed- 9 -LRB100 05102 MJP 15112 b
1adverse events; (6) potential food-drug interactions; and (7)
2the need to be compliant with the medication therapy. A
3pharmacy technician may only participate in the following
4aspects of patient counseling under the supervision of a
5pharmacist: (1) obtaining medication history; (2) providing
6the offer for counseling by a pharmacist or student pharmacist;
7and (3) acquiring a patient's allergies and health conditions.
8 (s) "Patient profiles" or "patient drug therapy record"
9means the obtaining, recording, and maintenance of patient
10prescription information, including prescriptions for
11controlled substances, and personal information.
12 (t) (Blank).
13 (u) "Medical device" means an instrument, apparatus,
14implement, machine, contrivance, implant, in vitro reagent, or
15other similar or related article, including any component part
16or accessory, required under federal law to bear the label
17"Caution: Federal law requires dispensing by or on the order of
18a physician". A seller of goods and services who, only for the
19purpose of retail sales, compounds, sells, rents, or leases
20medical devices shall not, by reasons thereof, be required to
21be a licensed pharmacy.
22 (v) "Unique identifier" means an electronic signature,
23handwritten signature or initials, thumb print, or other
24acceptable biometric or electronic identification process as
25approved by the Department.
26 (w) "Current usual and customary retail price" means the

SB0317 Engrossed- 10 -LRB100 05102 MJP 15112 b
1price that a pharmacy charges to a non-third-party payor.
2 (x) "Automated pharmacy system" means a mechanical system
3located within the confines of the pharmacy or remote location
4that performs operations or activities, other than compounding
5or administration, relative to storage, packaging, dispensing,
6or distribution of medication, and which collects, controls,
7and maintains all transaction information.
8 (y) "Drug regimen review" means and includes the evaluation
9of prescription drug orders and patient records for (1) known
10allergies; (2) drug or potential therapy contraindications;
11(3) reasonable dose, duration of use, and route of
12administration, taking into consideration factors such as age,
13gender, and contraindications; (4) reasonable directions for
14use; (5) potential or actual adverse drug reactions; (6)
15drug-drug interactions; (7) drug-food interactions; (8)
16drug-disease contraindications; (9) therapeutic duplication;
17(10) patient laboratory values when authorized and available;
18(11) proper utilization (including over or under utilization)
19and optimum therapeutic outcomes; and (12) abuse and misuse.
20 (z) "Electronic transmission prescription" means any
21prescription order for which a facsimile or electronic image of
22the order is electronically transmitted from a licensed
23prescriber to a pharmacy. "Electronic transmission
24prescription" includes both data and image prescriptions.
25 (aa) "Medication therapy management services" means a
26distinct service or group of services offered by licensed

SB0317 Engrossed- 11 -LRB100 05102 MJP 15112 b
1pharmacists, physicians licensed to practice medicine in all
2its branches, advanced practice nurses authorized in a written
3agreement with a physician licensed to practice medicine in all
4its branches, or physician assistants authorized in guidelines
5by a supervising physician that optimize therapeutic outcomes
6for individual patients through improved medication use. In a
7retail or other non-hospital pharmacy, medication therapy
8management services shall consist of the evaluation of
9prescription drug orders and patient medication records to
10resolve conflicts with the following:
11 (1) known allergies;
12 (2) drug or potential therapy contraindications;
13 (3) reasonable dose, duration of use, and route of
14 administration, taking into consideration factors such as
15 age, gender, and contraindications;
16 (4) reasonable directions for use;
17 (5) potential or actual adverse drug reactions;
18 (6) drug-drug interactions;
19 (7) drug-food interactions;
20 (8) drug-disease contraindications;
21 (9) identification of therapeutic duplication;
22 (10) patient laboratory values when authorized and
23 available;
24 (11) proper utilization (including over or under
25 utilization) and optimum therapeutic outcomes; and
26 (12) drug abuse and misuse.

SB0317 Engrossed- 12 -LRB100 05102 MJP 15112 b
1 "Medication therapy management services" includes the
2following:
3 (1) documenting the services delivered and
4 communicating the information provided to patients'
5 prescribers within an appropriate time frame, not to exceed
6 48 hours;
7 (2) providing patient counseling designed to enhance a
8 patient's understanding and the appropriate use of his or
9 her medications; and
10 (3) providing information, support services, and
11 resources designed to enhance a patient's adherence with
12 his or her prescribed therapeutic regimens.
13 "Medication therapy management services" may also include
14patient care functions authorized by a physician licensed to
15practice medicine in all its branches for his or her identified
16patient or groups of patients under specified conditions or
17limitations in a standing order from the physician.
18 "Medication therapy management services" in a licensed
19hospital may also include the following:
20 (1) reviewing assessments of the patient's health
21 status; and
22 (2) following protocols of a hospital pharmacy and
23 therapeutics committee with respect to the fulfillment of
24 medication orders.
25 (bb) "Pharmacist care" means the provision by a pharmacist
26of medication therapy management services, with or without the

SB0317 Engrossed- 13 -LRB100 05102 MJP 15112 b
1dispensing of drugs or devices, intended to achieve outcomes
2that improve patient health, quality of life, and comfort and
3enhance patient safety.
4 (cc) "Protected health information" means individually
5identifiable health information that, except as otherwise
6provided, is:
7 (1) transmitted by electronic media;
8 (2) maintained in any medium set forth in the
9 definition of "electronic media" in the federal Health
10 Insurance Portability and Accountability Act; or
11 (3) transmitted or maintained in any other form or
12 medium.
13 "Protected health information" does not include
14individually identifiable health information found in:
15 (1) education records covered by the federal Family
16 Educational Right and Privacy Act; or
17 (2) employment records held by a licensee in its role
18 as an employer.
19 (dd) "Standing order" means a specific order for a patient
20or group of patients issued by a physician licensed to practice
21medicine in all its branches in Illinois.
22 (ee) "Address of record" means the address recorded by the
23Department in the applicant's or licensee's application file or
24license file, as maintained by the Department's licensure
25maintenance unit.
26 (ff) "Home pharmacy" means the location of a pharmacy's

SB0317 Engrossed- 14 -LRB100 05102 MJP 15112 b
1primary operations.
2(Source: P.A. 98-104, eff. 7-22-13; 98-214, eff. 8-9-13;
398-756, eff. 7-16-14; 99-180, eff. 7-29-15.)
feedback